Update: Translation to Practice of an Intervention to Promote Colorectal Cancer Screening Among African Americans
The Georgia CTSA-supported Colorectal Cancer Screening Intervention Program (CCSIP) was recently featured on the NIH National Cancer Institute’s Division of Cancer Control & Populations Sciences’ Research to Reality. The Q&A interview also profiles partners through which the now R01-funded research was initiated utilizing a community-based participatory research approach, including Tabia Henry Akintobi, PhD, MPH director of the Georgia CTSA’s Community Engagement Program.
“The CCSIP was a community-based participatory research project that demonstrated the efficacy of a small group educational intervention in increasing screening for colorectal cancer among African Americans and is a wonderful contribution to advance health equity,” said Henry Akintobi.
The Community Engagement Program is a core component of a collaborative effort between Emory University, Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech), and University of Georgia (UGA). The program improves the way biomedical research is conducted and disseminated throughout Atlanta, the state, and across the country. Community Engagement works to unite existing academic-community research partnerships, facilitate community input into university research, and to increase health research in community settings that is both responsive and relevant to the health needs of the community.
The Georgia CTSA is a statewide partnership between Emory, MSM, Georgia Tech, and UGA and is one of over 60 in a national consortium striving to improve the way biomedical research is conducted across the country. The consortium, funded through the National Center for Advancing Translational Sciences (NCATS) and the National Institutes of Health’s Clinical and Translational Science Awards, shares a common vision to translate laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train the next generation of clinical investigators.